Eva-Maria Talvitie
- A pan-cancer analysis shows immunoevasive characteristics in NRF2 hyperactive squamous malignancies (2023)
- Redox biology
- Comprehensive genomic profiling of Finnish lung adenocarcinoma cohort reveals high clinical actionability and SMARCA4 altered tumors with variable histology and poor prognosis (2022)
- Neoplasia
- High tumor mutation burden predicts favorable outcome among patients with aggressive histological subtypes of lung adenocarcinoma: A population-based single-institution study (2020)
- Neoplasia